Microbot Medical Inc. (Nasdaq: MBOT) announced on October 23, 2026, that key executives and members of its commercial team will attend the SIR EDGE 2026 conference in Louisville, Kentucky, scheduled for October 25-27, 2026. The company stated that the event provides an opportunity to engage with prospective customers, specifically interventional radiologists, and decisionmakers from hospital administrators and health networks.
The filing notes that the conference will take place concurrently with the Association of Chiefs of Interventional Radiology (ACIR) Annual Fall Conference. Microbot Medical indicated this dual event allows the company to expand its national sales footprint and engage directly with Value Analysis Committees (VACs) at healthcare networks.
According to the filing, the LIBERTY Endovascular Robotic System is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures. The company aims to demonstrate the system's ability to reduce radiation exposure and physical strain during procedures.
Harel Gadot, Chairman, CEO and President of Microbot Medical, commented on the event. He stated that engaging with hundreds of potential users is invaluable and that the company has benefited from prior similar events to generate new leads. He noted that the goal is to meet jointly with physicians and administrators, share user feedback, and arrange demonstrations to initiate the sales process.
